Future studies should further investigate the effect of a long-term inflammatory blockade of the IL-1 system, using long-acting drugs (antibodies) or oral agents (inflammasome inhibitors) on clinical and biochemical hyperandrogenism and cardiovascular comorbidities in women with PCOS. Here, IL1B is linked to polycystic ovary syndrome.